The American Heart Association science advisory on depression and coronary heart disease: An exploration of the issues raised

Cleveland Clinic Journal of Medicine

Volumn 77, Issue SUPPL. 3, 2010, Pages

  Bigger, J Thomas ^a   Glassman, Alexander H ^a  

^a Columbia University College of Physicians and Surgeons ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARDIOLOGY; CORONARY ARTERY DISEASE; DEPRESSION; HUMAN; MEDICAL SOCIETY; MOTOR ACTIVITY; PATIENT COMPLIANCE; PRACTICE GUIDELINE; PSYCHOLOGICAL ASPECT; PSYCHOTHERAPY; QUESTIONNAIRE; REVIEW; STANDARD; TREATMENT OUTCOME; UNITED STATES;

AMERICAN HEART ASSOCIATION; CARDIOLOGY; CORONARY DISEASE; DEPRESSION; HUMANS; MOTOR ACTIVITY; PATIENT COMPLIANCE; PRACTICE GUIDELINES AS TOPIC; PSYCHOTHERAPY; QUESTIONNAIRES; TREATMENT OUTCOME; UNITED STATES;

EID: 77954721395     PISSN: 08911150     EISSN: None     Source Type: Journal    
DOI: 10.3949/ccjm.77.s3.03     Document Type: Review

References (44)

1. Lichtman JH, Bigger JT Jr, Blumenthal JA, et al. Depression and coronary heart disease: recommendations for screening, referral, and treatment. A science advisory from the American Heart Association Prevention Committee of the Council on Cardiovascular Nursing, Council on Clinical Cardiology, Council on Epidemiology and Prevention, and Interdisciplinary Council on Quality of Care and Outcomes Research; endorsed by the American Psychiatric Association. Circulation 2008; 118:1768-1775.
2. Kessler RC, Merikangas KR, Wang PS. Prevalence, comorbidity, and service utilization for mood disorders in the United States at the beginning of the twenty-first century. Annu Rev Clin Psychol 2007; 3:137-158.
3. Wulsin LR, Singal BM. Do depressive symptoms increase the risk for the onset of coronary disease? A systematic quantitative review. Psychosom Med 2003; 65:201-210.
4. Berkman LF, Blumenthal J, Burg M, et al. Effects of treating depression and low perceived social support on clinical events after myocardial infarction: the Enhancing Recovery in Coronary Heart Disease Patients (ENRICHD) randomized trial. JAMA 2003; 289:3106-3116.
5. Thombs BD, Bass EB, Ford DE, et al. Prevalence of depression in survivors of acute myocardial infarction. J Gen Intern Med 2006; 21:30-38.
6. van Melle JP, de Jonge P, Spijkerman TA, et al. Prognostic association of depression following myocardial infarction with mortality and cardiovascular events: a meta-analysis. Psychosom Med 2004; 66:814-822.
7. Kroenke K, Spitzer RL, Williams JB. The Patient Health Questionnaire-2: validity of a two-item depression screener. Med Care 2003; 41:1284-1292.
8. Whooley M, Avins AL, Miranda J, Brown WS. Case-finding instruments for depression: two questions are as good as many. J Gen Intern Med 1997; 12:289-290.
9. Gilbody S, Richards D, Brealey S, Hewitt C. Screening for depres sion in medical settings with the Patient Health Questionnaire (PHQ): a diagnostic meta-analysis. J Gen Intern Med 2007; 22:1596-1602.
10. Stafford L, Berk M, Jackson HJ. Validity of the Hospital Anxiety and Depression Scale and Patient Health Questionnaire-9 to screen for depression in patients with coronary artery disease. Gen Hosp Psychiatry 2007; 29:417-424.
11. McManus D, Pipkin SS, Whooley MA. Screening for depression in patients with coronary heart disease (data from the Heart and Soul Study). Am J Cardiol 2005; 96:1076-1081.
12. U.S. Preventive Services Task Force. Screening for depression: recommendations and rationale. Rockville, MD: Agency for Healthcare Research and Quality; May 2002. http://www.ahrq.gov/clinic/3rduspstf/depression/depressrr.htm. Accessed January 8, 2010.
13. Depression Guideline Panel. Clinical Practice Guideline Number 5: Depression in Primary Care, 1: Detection and Diagnosis. Rockville, MD: US Department of Health and Human Services, Public Health Service, Agency for Health Care Policy and Research; April 1993. AHCPR publication 93-0550.
14. Depression Guideline Panel. Clinical Practice Guideline Number 5: Depression in Primary Care, 2: Treatment of Major Depression. Rockville, MD: US Department of Health and Human Services, Public Health Service, Agency for Health Care Policy and Research; April 1993. AHCPR publication 93-0551.
15. DiMatteo MR, Lepper HS, Croghan TW. Depression is a risk factor for noncompliance with medical treatment: meta-analysis of the effects of anxiety and depression on patient adherence. Arch Intern Med 2000; 160:2101-2107.
16. Glassman AH, Bigger JT, Gaffney M. Psychiatric characteristics associated with long-term mortality among 361 patients having an acute coronary syndrome and major depression: seven-year follow-up of SADHART participants. Arch Gen Psychiatry 2009; 66:1022-1029.
17. Glassman AH, O'Connor CM, Califf RM, et al. Sertraline treatment of major depression in patients with acute MI or unstable angina. JAMA 2002; 288:701-709.
18. Taylor CB, Youngblood ME, Catellier D, et al. Effects of antidepressant medication on morbidity and mortality in depressed patients after myocardial infarction. Arch Gen Psychiatry 2005; 62:792-798.
19. Lesperance F, Frasure-Smith N, Koszycki D, et al. Effects of citalopram and interpersonal psychotherapy on depression in patients with coronary artery disease: the Canadian Cardiac Randomized Evaluation of Antidepressant and Psychotherapy Efficacy (CREATE) trial. JAMA 2007; 297:367-379.
20. Honig A, Kuyper A, Schene AH, et al. Treatment of post-myocardial infarction depressive disorder: a randomized, placebo-controlled trial with mirtazapine. Psychosom Med 2007; 69:606-613.
21. Strik J, Honig A, Lousberg R, et al. Efficacy and safety of fl uoxetine in the treatment of patients with major depression after first myocardial infarction: findings from a double-blind, placebo-controlled trial. Psychosom Med 2000; 62:783-789.
22. American Psychiatric Association. Practice guideline for the treatment of patients with major depressive disorder (revision). Am J Psychiatry 2000; 157(suppl 4):1-45.
23. Beck AT. Cognitive Therapy and the Emotional Disorders. Madison, CT: International Universities Press Inc; 1975.
24. Weissman MM. A brief history of interpersonal psychotherapy. Psychiatr Ann 2006; 36:553-557.
25. Klerman GL, Weissmann MM. Interpersonal psychotherapy (IPT) and drugs in the treatment of depression. Pharmacopsychiatry 1987; 20:3-7.
26. Burg MM, Lespérance F, Rieckmann N, Clemow L, Skotzko C, Davidson KW. Treating persistent depressive symptoms in postACS patients: the project COPES phase-I randomized controlled trial. Contemp Clin Trials 2008; 29:231-240.
27. Davidson KW, Rieckmann N, Clemow L, et al. Collaborative depression care for acute coronary syndrome patients with persistent depression: Coronary Psychosocial Evaluation Studies (COPES) randomized controlled trial. Arch Intern Med. In press.
28. Brosse AL, Sheets ES, Lett HS, Blumenthal JA. Exercise and the treatment of clinical depression in adults: recent findings and future directions. Sports Med 2002; 32:741-760.
29. Milani RV, Lavie CJ. Impact of cardiac rehabilitation on depression and its associated mortality. Am J Med 2007; 120:799-806.
30. Smith SC Jr, Allen J, Blair SN, et al. AHA/ACC guidelines for secondary prevention for patients with coronary and other atherosclerotic vascular disease: 2006 update; endorsed by the National Heart, Lung, and Blood Institute. Circulation 2006; 113:2363-2372.
31. Thombs BD, de Jonge P, Coyne JC, et al. Ziegelstein RC. Depression screening and patient outcomes in cardiovascular care: a systematic review. JAMA 2008; 300:2161-2171.
32. Mitchell AJ, Vaze A, Rao S. Clinical diagnosis of depression in primary care: a meta-analysis. Lancet 2009; 374:609-619.
33. Gilbody S, Bower P, Fletcher J, Richards D, Sutton AJ. Collaborative care for depression: a cumulative meta-analysis and review of longer-term outcomes. Arch Intern Med 2006; 166:2314-2321.
34. Glassman AH, Bigger JT, Gaffney M, Shapiro PA, Swenson JR. Onset of major depression associated with acute coronary syndromes: relationship of onset, major depressive disorder history, and episode severity to sertraline benefit. Arch Gen Psychiatry 2006; 63:283-288.
35. Carney RM, Freedland KE. Treatment-resistant depression and mortality after acute coronary syndrome. Am J Psychiatry 2009; 166:410-417.
36. Pignone MP, Gaynes BN, Rushton JL, et al. Screening for depression in adults: a summary of the evidence for the U.S. Preventive Services Task Force. Ann Intern Med 2002; 136:765-776.
37. Alexopoulos GS, Reynolds CF III, Bruce ML, et al. Reducing suicidal ideation and depression in older primary care patients: 24-month outcomes of the PROSPECT study. Am J Psychiatry 2009; 166:882-890.
38. Mukherjee D, Fang J, Chetcuti S, Moscucci M, Kline-Rogers E, Eagle KA. Impact of combination evidence-based medical therapy on mortality in patients with acute coronary syndromes. Circulation 2004; 109:745-749.
39. Eagle KA, Kline-Rogers E, Goodman SG, et al. Adherence to evidence-based therapies after discharge for acute coronary syndromes: an ongoing prospective, observational study. Am J Med 2004; 117:73-81.
40. Rieckmann N, Gerin W, Kronish IA, et al. Course of depressive symptoms and medication adherence after acute coronary synromes: an electronic medication monitoring study. J Am Coll Cardiol 2006; 48:2218-2222.
41. Ziegelstein RC, Fauerbach JA, Stevens SS, Romanelli J, Richter DP, Bush DE. Patients with depression are less likely to follow recommendations to reduce cardiac risk during recovery from a myocardial infarction. Arch Intern Med 2000; 160:1818-1823.
42. Whooley MA, de Jonge P, Vittinghoff E, et al. Depressive symptoms, health behaviors, and risk of cardiovascular events in patients with coronary heart disease. JAMA 2008; 300:2379-2388.
43. Blumenthal JA, Babyak MA, Doraiswamy PM, et al. Exercise and pharmacotherapy in the treatment of major depressive disorder. Psychosom Med 2007; 69:587-596.
44. Blumenthal JA, Sherwood A, Rogers SD, et al. Understanding prognostic benefits of exercise and antidepressant therapy for persons with depression and heart disease: the UPBEAT study-rationale, design, and methodological issues. Clin Trials 2007; 4:548-559.